Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-17
    E.g., 2018-10-17

Archive Search

1 results
12:00 AM, Mar 16, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Beteflam Patch regulatory update

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga …
deal granting Cipher marketing rights to the product in Canada (see BioCentury, Aug. 13, 2012). Beteflam Patch
self-adhesive medicated plaster containing 0.1% betamethasone valerate. Institut Biochimique S.A. , Lugano, Switzerland   Product: Beteflam Patch